Details for New Drug Application (NDA): 202872
✉ Email this page to a colleague
The generic ingredient in LOTEMAX is loteprednol etabonate. There are ten drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the loteprednol etabonate profile page.
Summary for 202872
Tradename: | LOTEMAX |
Applicant: | Bausch And Lomb Inc |
Ingredient: | loteprednol etabonate |
Patents: | 0 |
Pharmacology for NDA: 202872
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 202872
Suppliers and Packaging for NDA: 202872
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LOTEMAX | loteprednol etabonate | GEL;OPHTHALMIC | 202872 | NDA | Bausch & Lomb Incorporated | 24208-503 | 24208-503-07 | 1 BOTTLE in 1 CARTON (24208-503-07) / 5 g in 1 BOTTLE |
LOTEMAX | loteprednol etabonate | GEL;OPHTHALMIC | 202872 | NDA | Bausch & Lomb Incorporated | 24208-503 | 24208-503-48 | 1 BOTTLE in 1 CARTON (24208-503-48) / .5 g in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | GEL;OPHTHALMIC | Strength | 0.5% | ||||
Approval Date: | Sep 28, 2012 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 202872
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch And Lomb Inc | LOTEMAX | loteprednol etabonate | GEL;OPHTHALMIC | 202872-001 | Sep 28, 2012 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription